肺心病急性加重期采用低分子肝素联合酚妥拉明治疗的临床疗效分析

《肺心病急性加重期采用低分子肝素联合酚妥拉明治疗的临床疗效分析》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。

1、肺心病急性加重期采用低分子肝素联合酚妥拉明治疗的临床疗效分析阿依提拉汗?艾力(新疆乌鲁木齐市水磨沟区人民医院830017)【摘要】A的：评价肺心病急性加重期采用低分子肝素联合酚妥拉明治疗的的临床效果。方法:选取入住我院进行治疗的肺心病急性加重期患者200名，按照完全随机抽样的方法，随机分为2个组：对照组、实验组。对照组采用常规疗法，实验组在常规疗法基础上采用低分子肝素和酚妥拉明的联合疗法。观察并比较两组患者的治疗情况。结果：患者经过治疗后，实验组总有效率为88.00%,对照组总有效率为49.00%,实验组明显高于对照组，具有统计学意义(P<0.05)；实验组血液全血粘度

2、、血浆粘度和红细胞聚集指数在治疗前后具有显著差异(P<0.05)且较对照组三项指标均具有显著性差异，具有统计学意义(P<0.05)o结论：在对肺心病急性加重期患者进行治疗的过程屮，通过采用低分子肝素和酚妥拉明的联合治疗，效果显著，急性加重期患者疾病状况明显改善,可在临床上广泛应用。【关键词】肺心病急性加重期低分子肝素酚妥拉明【屮图分类号】R541.5【文献标识码】A【文章编号】2095-1752(2014)19-0068-02Analyzedtheclinicaleffectoflowmolecularheparincombinewithphentolaminei

3、ntreatmentofacuteexacerbationofpulmonaryheartdisease[Abstract]Objective:Toevaluatedthelowmolecularheparincombinewithphentolamineintreatmentofacuteexacerbationofpulmonaryheartdisease.Methods:200patientswithacuteexacerbationofpulmonaryheartdiseaseinourhospitalwereselected,anddividedthemintoco

4、ntrolgroupandexperimentalgroupbyrandomly.Thecontrolgroupwastreatedbyroutinetreatment,andtheexperimentalgroupwastreatedbylowmolecularheparincombinewithphentolamineonthebasisofroutinetreatment.Toobservedandcomparedthetreatmentoftwogroups’patients.Results:Thepatientsaftertreatment,thetot

5、alefficiencyofexperimentalgroupwas88%,thetotalefficiencyofcontrolgroupwas49%,theexperimentalgroupwassignificantlyhigherthancontrolgroup,differenceswerestatisticallysignificant(P<0.05);thebloodviscosityofwholeblood,plasmaviscosityanderythrocyteaggregationindexofexperimentalgroupbeforeanda

6、ftertherapyhadsignificantdifferences(P<0.05),andcomparedwiththecontrolgroupofthreeindicators,differenceswerestatisticallysignificant(P<0.05).Conclusion:Inthecourseofacuteexacerbationofpulmonaryheartdiseasepatientstreatedbycombinationtherapyusinglowmolecularweightheparinandphentolamine

7、,theeffectissignificant,inpatientswithacuteexacerbationofdiseasestatusimprovedsignificantly,it’sworthyofbeingappliedinclinic.【Keywords］pulmonaryheartdiseaseacuteexacerbationlowmolecularweightheparinphentolamine肺心病全称为肺源性心脏病，是0前社会威胁人类生命安全的一大呼吸系统疾病，尤其